GS
TERN

George Soros’s Terns Pharmaceuticals TERN Stock Holding History

George Soros’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-321,905
Closed -$17M – 324
2026
Q1 		$17M Buy
+321,905
New +$13.2M 0.19% 118

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

George Soros's TERN Position: Q2 2026 in Review

George Soros sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 321,905 shares — an estimated $17M sold.

George Soros first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $17M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • George Soros reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • George Soros sold 321,905 Terns Pharmaceuticals shares in Q2 2026, an estimated $17M.
  • George Soros first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • George Soros's Terns Pharmaceuticals position peaked at $17M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Soros Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.